Opioid Treatment Program (OTP) Development
Opioid Treatment Program (OTP) Development Consulting
Opioid Treatment Programs that dispense methadone for the treatment of opioid use disorder are subject to a unique set of federal requirements administered by the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Drug Enforcement Administration (DEA). These regulations govern everything from the physical dispensing facility to staffing ratios, take-home medication schedules, counseling requirements, and medical director qualifications.
Despite this complexity, OTPs remain among the most effective evidence-based treatments available for opioid use disorder. Well-run programs significantly reduce overdose mortality, criminal justice involvement, and comorbid health conditions among the populations they serve. Our OTP consultants have helped organizations launch new programs and strengthen existing ones — navigating federal requirements without losing sight of the clinical mission.
Regulatory Framework We Navigate
42 CFR Part 8 — Federal methadone regulations governing OTP certification, staffing, dosing, take-home privileges, and recordkeeping
SAMHSA OTP Certification — Federal certification application and ongoing compliance with SAMHSA's Division of Pharmacologic Therapies (DPT)
DEA Schedule II Registration — Federal DEA registration for methadone dispensing, including security requirements, inventory controls, and diversion prevention
State OTP Licensure — Many states impose additional requirements beyond federal regulations, including state-specific staffing ratios, facility standards, and reporting obligations
Accreditation Requirements — Most OTPs are required to be accredited by a SAMHSA-approved accrediting body (CARF, The Joint Commission, or ACHC)
Service Areas
OTP Feasibility & Market Assessment — Community need analysis, competitive landscape review, and financial viability modeling for a proposed OTP
SAMHSA Certification Application — Full application preparation and submission support for new OTP federal certification
DEA Registration Guidance — Documentation and process support for Schedule II DEA registration and security compliance
State Licensure Applications — State-specific OTP licensure application preparation in all applicable states
Facility Design Guidance — Consultation on dispensing window design, medication storage, waiting area layout, and physical security requirements
Clinical Program Design — Evidence-based counseling protocols, dosing algorithms, take-home criteria, and co-occurring disorder treatment integration
Policies & Procedures Manual — A complete OTP policy manual covering all federal, state, and accreditation requirements
Staff Training — Medical director, nursing, counseling, and administrative staff training on OTP regulations and clinical best practices
Ready to Build or Strengthen Your SUD Program?
Buprenorphine-based office-based opioid treatment (OBOT) programs operate under a different regulatory framework than methadone OTPs. We support both models, as well as hybrid programs offering both medications based on patient clinical need.
Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.
The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.
HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws.
© 2026 HealthBridge US, a California corporation. All rights reserved.
For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance
Legal
Resources
Based in Los Angeles, California, operating in all 50 states.
